Clinical Trial Update: Molecular Adsorbent Recirculating System (MARS®) in Hypoxic Hepatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the MARS liver support system for hypoxic/ischemic liver injury. Current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic Hepatitis
• Ischemic Hepatitis
• Liver Failure

Drugs mentioned

• MARS (Molecular Adsorbent Recirculating System)

Snippet

Sponsor: Medical University of Vienna | Conditions: Hypoxic Hepatitis, Ischemic Hepatitis | Phase 2 | Status: UNKNOWN